BE.Amycon Registry UZ Leuven

Universitaire Ziekenhuizen KU Leuven

Status: Suspended

Conditions: Amyloidosis

Treatments: Other: Registry

Study type: Observational

Funder types: Other

Identifiers

NCT06998355

BE.AMYCON_UZL_WP2_01

Details and patient eligibility

About

The goal of this observational study is to establish database with (limited) personal and health data of patients diagnosed with amyloidosis (any subtype) in order to get better insights on the disease presentation, disease evolution pattern, treatment plans and responses and survival.

Full description

With the support of VIB Grand Challenges Program, this project aims to establish the BElgian AMYloidosis CONsortium (BE.AMYCON) by joining forces of VIB researchers, a state-of-the-art diagnostic platform, and clinicians from various disciplines and different institutes. Such a consortium will address patient needs and improve outcomes on many levels.

In this context, a registry of clinical data is a requirement for both improvement of diagnostics as well as fundamental research purposes.

Enrollment: 550 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 years or older
• Provide consent and sign informed consent form
• Confirmed diagnosis of amyloidosis (any subtype), systemic and/or localised
• Newly diagnosed or in follow-up during the study time-frame (1 JUN 2025 until 31 DEC 2027)

Exclusion criteria

• Not able to provide informed consent
• Not willing to sign informed consent